These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31001260)

  • 1. A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.
    Reed AM; Crowson CS; Dvergsten JA
    Front Immunol; 2019; 10():638. PubMed ID: 31001260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.
    Rider LG; Nistala K
    J Intern Med; 2016 Jul; 280(1):24-38. PubMed ID: 27028907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
    Hou Y; Liu M; Luo YB; Sun Y; Shao K; Dai T; Li W; Zhao Y; Yan C
    Neuromuscul Disord; 2019 Jan; 29(1):5-13. PubMed ID: 30579751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Features of Myositis-Associated Autoantibodies: a Review.
    Gunawardena H
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):45-57. PubMed ID: 26453338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myositis in clinical practice-relevance of new antibodies.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):887-901. PubMed ID: 31427061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.
    Tansley SL; McHugh NJ
    Curr Rheumatol Rep; 2014 Dec; 16(12):464. PubMed ID: 25467551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Miller FW
    Rheum Dis Clin North Am; 1997 Aug; 23(3):619-55. PubMed ID: 9287380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic myopathy.
    Dankó K; Ponyi A; Molnar AP; András C; Constantin T
    Curr Opin Rheumatol; 2009 Nov; 21(6):594-8. PubMed ID: 19730376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
    Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.
    Habers GE; Huber AM; Mamyrova G; Targoff IN; O'Hanlon TP; Adams S; Pandey JP; Boonacker C; van Brussel M; Miller FW; van Royen-Kerkhof A; Rider LG;
    Arthritis Rheumatol; 2016 Mar; 68(3):761-8. PubMed ID: 26474155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M; Nishino I
    Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.